Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1300 participants
INTERVENTIONAL
2025-10-13
2028-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Low Pressure Pneumo in RARP II
NCT04394676
Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate
NCT00632138
EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER
NCT06822036
A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy
NCT06671782
The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy
NCT06397040
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PRELIMINARY DATA:
The first version of Pip included three pathways (nutrition, fitness, and smoking cessation). In a pilot study with the Center for Perioperative Center (CPC) at the University of Pittsburgh Medical Center (UPMC), implementation of Pip resulted in the reduction of the median length of stay (LOS) by one day. The same-day surgery cancellations were avoided 99.5 % of the time. Pip also received an aggregate patient satisfaction score of 4.8 out of 5 (vs. industry benchmarks of 3.8-4.3).
Pip Care partnered with the UPMC CPC to digitize and implement clinical pathways, created by perioperative experts at UPMC, into modular digital care contents. Pip Care, CPC, and surgical offices developed a workflow that was both operationally and clinically seamless. The Pip DHP was designed to replace the time-consuming clinic follow-ups and care coordination through the different phases of the perioperative process. In addition to Health Coach follow-up, patients were invited to not only receive notifications and report outcomes, but to explore a library of educational multimedia resources on disease processes and why optimization of said diseases is important prior to surgery. Pip also identified patients who were not engaging with the clinical team and offered further remediation to help prevent poor outcomes.
Pip Digital Platform Development. The Pip technology platform is powered by two connected components: (1) Back-end platform utilized by health coaches and (2) Front-end native digital mobile application utilized by patients. The front-end digital mobile application contains four key features, which are represented by separate pages within the digital application: (1) Pip My Plan, which displays when patients are assigned personalized care plans and tasks by their Health Coach, (2) Pip Appointments, which patients schedule and join weekly video or voice calls with the Health Coach, (3) Pip Messages patients have access to unlimited engagement with their Health Coach, and (4) a library of health system-approved education content, including articles and videos, to assist with their surgery preparation and recovery. Figure 4 summarizes the initial Pip care plans: 8 total care plans including 3 clinical pathways (smoking cessation, weight management, and nutrition). To make the application patient-centered and accessible to all with mobile technology while improving communication, language for the application (e.g., questions, answers, instructions), and other content within the application are presented at a maximum reading level of the eighth grade. Pip is designed to function on both iOS (Apple Inc, Cupertino, CA) and Android (Google Inc, Mountain View, CA) operating systems.
Case Matched Pilot Clinical Study. A pilot clinical study at UPMC recently demonstrated feasibility and improved outcomes in case matched patients. The investigators have developed and validated the feasibility of the Pip Care digital platform with Health Coach and digital protocols. This was a Quality Improvement approved descriptive, prospective feasibility study of patients scheduled for elective surgery, invited to enroll in Pip from 2.5-4 weeks preoperatively through 4 weeks postoperatively at UPMC between 11/2/2022 - 3/27/2023. Descriptive primary endpoints included patient satisfaction, patient engagement, Pip Health Coach evaluations, and other PROs. Secondary endpoints included length of stay (LOS), readmission rates, and emergency department utilization rates within 30 days. Mean age was 64 years.
High Engagement and Satisfaction Scores. Our primary outcomes focused on feasibility of deployment of the combined platform and the patient assessment of the experience. Out of 283 patients invited to Pip, 172 patients (61%) were enrolled compared to industry benchmarks between (5% and 30%). Of those enrolled, 143 (83%) had one or more Health Coach sessions. During the study, of the patients who had one or more Health Coach sessions, 138 (97%) proceeded to surgery, a 4-8% improvement compared to industry benchmarks (90-93%). After surgery, 97 (70%) patients engaged with Pip postoperatively, a 35-126% improvement compared to industry benchmarks (31-52%). Pip received a total of 95 patient satisfaction survey submissions. Patients reported an overall high satisfaction based on the satisfaction survey (average score 4.8 out of 5, n=95). Patients strongly agree that Health Coach helped them throughout the perioperative process based on Pip Health Coach evaluation (average score 4.97 out of 5, n=33). The average Net Promotor Score, a customer experience metric, was 9.7 out of 10.
LOS and Readmission. Stabilized inverse probability of treatment weighting (SIPTW) was created to reduce selection bias and balance the patient characteristics (i.e., age, procedures, and perioperative risk score) in Pip and non-Pip cohorts. A total of 128 patients in the Pip cohort were compared to 268 patients in the non-Pip cohort. Pip was significantly associated with a 24% reduction in postoperative LOS (mean 2.4 vs. 3.1 days; median 1.9 vs. 3.0 days; mean ratio: 0.76; 95%CI: 0.62-0.93). Pip was associated with a 49% lower risk in 7-day readmission (relative risk: 0.51; 95%CI: 0.11-2.31) and 17% lower risk in 30-day readmission (relative risk: 0.83; 95%CI: 0.30-2.31), though not statistically significant. Pip and non-Pip groups had similar risk in 30-day ED returns (relative risk: 1.06; 95%CI: 0.56-2.01).
Patient Feedback to the Health Coach. An overwhelmingly positive aspect was the patient feedback and response to the Health Coach. The following comments support current evidence that high level engagement is very important to patients and their outcomes
"This has been a medical experience I will not forget. \[The Health Coach\] was patient and kind and encouraging. His support was vital to my experience." - Patient
"Talking to \[the Health Coach\] has helped me to feel a bit better and know that I am doing all that is in control to get ready for surgery." - Patient
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pip Care Intervention Group
Subjects randomized to the Pip Care Intervention group will receive access to the Pip Care digital health platform 1-week prior to their scheduled elective, inpatient surgery and retain access to the digital health platform for 30-days following surgery.
Pip Care Digital Health Platform
Pip Care Digital Health Platform is a smartphone application granting access to a health coach who will assist the patient in completing a health intake, creating personalized perioperative care plans, and meets regularly with the patient to encourage goal accomplishments and supports healthy surgical recovery.
Standard of Care Group
Subjects randomized to the standard of care group will receive routine standard of care for their planned elective, inpatient surgery.
Standard of Care Protocol
Subjects in this intervention group will receive routine, standard of care throughout their surgery and hospital stay as determined by their acting clinical care team.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pip Care Digital Health Platform
Pip Care Digital Health Platform is a smartphone application granting access to a health coach who will assist the patient in completing a health intake, creating personalized perioperative care plans, and meets regularly with the patient to encourage goal accomplishments and supports healthy surgical recovery.
Standard of Care Protocol
Subjects in this intervention group will receive routine, standard of care throughout their surgery and hospital stay as determined by their acting clinical care team.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Planned elective, inpatient surgery between 2 to 8 weeks following enrollment in Pip within the following surgical specialties: complex abdominal surgery (general surgery, colorectal surgery, surgical oncology), gynecologic oncology, thoracic surgery, spine surgery, and orthopedic joint surgery
3. Daily access to a smartphone or tablet.
Exclusion Criteria
2. Unable to use a smartphone or tablet independently or with daily assistance.
3. Currently pregnant (assessed via standard-of-care pre-operative workup)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Holder-Murray
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Holder-Murray, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh, UPMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Jameson Hospital
New Castle, Pennsylvania, United States
UPMC East Hospital
Pittsburgh, Pennsylvania, United States
UPMC Horizon
Pittsburgh, Pennsylvania, United States
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania, United States
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, United States
UPMC St. Margaret
Pittsburgh, Pennsylvania, United States
UPMC Shadyside Hospital
Pittsburgh, Pennsylvania, United States
UPMC Passavant Hospital
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY25010036
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.